Treatment of hepatitis c with thymosin, interferon and ribavirin

Details for Australian Patent Application No. 2001283536 (hide)

Owner Sci-Clone Pharmaceuticals Inc

Inventors Rudolph, Alfred R.

Agent Wrays

Pub. Number AU-B-2001283536

PCT Pub. Number WO02/11749

Priority 60223317 07.08.00 US

Filing date 6 August 2001

Wipo publication date 18 February 2002

Acceptance publication date 1 September 2005

International Classifications

A61K 038/00 Medicinal preparations containing peptides

A61K 038/21 Medicinal preparations containing peptides - Interferons

A61K 031/70 - Carbohydrates

Event Publications

1 September 2005 Application Accepted

  Published as AU-B-2001283536

5 January 2006 Standard Patent Sealed

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001283537-Stable enzymatic wound debrider

2001283535